Trinidad & Tobago STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago STEM News.

Press releases published on August 3, 2026

Aug. 3, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Aug. 3, 2026

Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom

Indeterminate GlobeNewswire

Aug. 3, 2026

OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor July Payment Volume Increased 107.6% Month Over Month

Indeterminate GlobeNewswire

Aug. 3, 2026

Veritasium Goes Behind the Scenes at Kraig Biocraft Laboratories to Explore the Future of Commercial Spider Silk

Indeterminate GlobeNewswire

Aug. 3, 2026

PCI SSC Europe Community Meeting feiert 20-jähriges Jubiläum und kehrt nach Edinburgh zurück

Indeterminate GlobeNewswire

Aug. 3, 2026

Le PCI SSC Europe Community Meeting revient à Édimbourg pour célébrer son 20e anniversaire

Indeterminate GlobeNewswire

Aug. 3, 2026

Blancco Leaders to Speak at ITAD Summit on Building Smarter, More Efficient IT Asset Processing Operations

Indeterminate GlobeNewswire

Aug. 3, 2026

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Indeterminate GlobeNewswire

Aug. 3, 2026

VisionWave Files International Trademark Application for STRATUM™ AI Platform

Indeterminate GlobeNewswire

Aug. 3, 2026

Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia

Indeterminate GlobeNewswire

Aug. 3, 2026

Palomino Laboratories Completes Vega Links Acquisition and Strengthens Technology Leadership to Accelerate Next-Generation AI Interconnect Development

Indeterminate GlobeNewswire

Aug. 3, 2026

Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.

Indeterminate GlobeNewswire

Aug. 3, 2026

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

Indeterminate GlobeNewswire

Aug. 3, 2026

Aurora Mobile's GPTBots.ai Launches LoopAgent: Production-Grade Execution That Runs Complex Tasks End-to-End

Indeterminate GlobeNewswire

Aug. 3, 2026

OutSolve Earns Two-Star Certification from The DaVinci Awards®

Indeterminate GlobeNewswire

Aug. 3, 2026

Lantronix CEO and CFO to Participate in Canaccord Genuity and Needham Conferences

Indeterminate GlobeNewswire

Aug. 3, 2026

Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Aug. 3, 2026

EVA LIVE INC. ANNOUNCES FORMATION OF EVA DEFENSE ADVISORY BOARD, APPOINTS GENERAL ROBERT BROOKS BROWN (R) AND ROSS MANDEL

Indeterminate GlobeNewswire

Aug. 3, 2026

Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Aug. 3, 2026

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

Indeterminate GlobeNewswire